Synergistic Effect of HAD-B1 and Osimertinib Against Gefitinib Resistant HCC827 Non-Small Cell Lung...
Synergistic Effect of HAD-B1 and Osimertinib Against Gefitinib Resistant HCC827 Non-Small Cell Lung Cancer Cells
About this item
Full title
Author / Creator
Publisher
United States: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
United States: SAGE Publications
Subjects
More information
Scope and Contents
Contents
In this study, we investigated the synergistic effect of co-administration of osimertinib and HAD-B1 using gefitinib-resistant non-small cell lung cancer cells, HCC827-GR. HAD-B1 is composed of 4 natural drugs, Panax Notoginseng Radix, Panax ginseng C. A. Meyer, Cordyceps militaris, and Boswellia carterii Birdwood, and has been reported to have the...
Alternative Titles
Full title
Synergistic Effect of HAD-B1 and Osimertinib Against Gefitinib Resistant HCC827 Non-Small Cell Lung Cancer Cells
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_44cc8d37190145ecaeea61988076d257
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_44cc8d37190145ecaeea61988076d257
Other Identifiers
ISSN
1534-7354,1552-695X
E-ISSN
1552-695X
DOI
10.1177/15347354241307006